IDR Data
CMS PUF data · 2023 Q1–2025 Q4

CPT 85380: Federal IDR outcomes

Coagulation function measurement, ultrasensitive, qualitative or semiquantitative

In 2025 Q1–Q4, the provider or facility offer prevailed in 77.7% of 224 determined Federal IDR dispute line items for CPT 85380. The median prevailing offer was 5.88x the QPA (25th–75th percentile 1.22x–11.06x; n = 60). The median time to a decision was 27 business days (n = 224).

Determined line items

224

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

77.7%

n = 224 · 2025 Q1–Q4

Median payment vs QPA

5.88x

middle half 1.22x–11.06x · n = 60 · 2025 Q1–Q4

Median days to decision

27

business days, from dispute initiation · n = 224 · 2025 Q1–Q4

Dollar amounts

Total awarded

$33,856

sum of prevailing offers · n = 51 · 2025 Q1–Q4

Total QPA

$10,019

sum of QPAs, same line items · n = 51 · 2025 Q1–Q4

Awarded above QPA

$23,837

total awarded minus total QPA · n = 51 · 2025 Q1–Q4

Median award per line item

$788

mean $664 · n = 51 · 2025 Q1–Q4

Median QPA

$102

per line item · n = 51 · 2025 Q1–Q4

Award vs QPA, dollar-weighted

3.38x

total awarded ÷ total QPA · n = 51 · 2025 Q1–Q4

Dollar amounts come from the separate CMS “QPA and Offers” file: line items decided for the provider or the plan with a non-suppressed QPA and prevailing offer. That file cannot be joined to the line items above, so its n differs. Awarded = the prevailing (selected) offer; it is not a record of what was paid. State comes from the file’s geographic region; a metro area that spans states counts in each. How the dollar figures work

Dollar amounts by period

PeriodLine items with $Total awardedTotal QPAAbove QPAMedian awardMedian QPAAward ×QPA ($-weighted)
2025 Q1–Q451$33,856$10,019$23,837$788$1023.38x
2024 Q3–Q4Fewer than 30 line items with dollar amounts; not shown.
2024 Q3–2025 Q451$33,856$10,019$23,837$788$1023.38x
2023 Q1–2024 Q2Not available (see methodology).

From the CMS QPA and Offers file (see above). Award ×QPA here is total awarded ÷ total QPA, so large claims weigh more than in the per-line median ratio.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q422477.7%5.88x1.22x–11.06x6027
2024 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q426770.0%5.88x1.21x–10.86x62not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

By state

State (place of service)Line itemsWin %Median ×QPARatio nMedian days
Texas20978.0%5.88x6028

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

By specialty

Specialty groupLine itemsWin %Median ×QPARatio nMedian days
Emergency medicine and emergency departments12690.5%5.88x6027
Not reported / unspecified9760.8%–027

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Section: Pathology and laboratory (80047–89398)

FAQ

What is the Federal IDR provider win rate for CPT 85380?

In 2025 Q1–Q4, the provider or facility offer was selected in 77.7% of 224 determined dispute line items for CPT 85380. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for CPT 85380?

In 2025 Q1–Q4, the median prevailing offer was 5.88x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 1.22x to 11.06x (n = 60 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for CPT 85380?

In 2025 Q1–Q4, the median was 27 business days (n = 224 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR